BBHC
UTMD icon

Brown Brothers Harriman & Co’s Utah Medical Products UTMD Stock Holding History

Brown Brothers Harriman & Co’s Portfolio UTMD Stock Details UTMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-13
Closed -$806 – 1888
2026
Q1 		$806 Hold
13
– – ﹤0.01% 1745
2025
Q4 		$727 Hold
13
– – ﹤0.01% 1790
2025
Q3 		$819 Hold
13
– – ﹤0.01% 1638
2025
Q2 		$740 Buy
+13
New +$707 ﹤0.01% 1497

Other funds holding UTMD

BIP
Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
MA
Minerva Advisors Bala Cynwyd, Pennsylvania $158M AUM 42.05% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Brown Brothers Harriman & Co's UTMD Position: Q2 2026 in Review

Brown Brothers Harriman & Co sold out of Utah Medical Products (UTMD) in Q2 2026, closing a stake of 13 shares — an estimated $806 sold.

Brown Brothers Harriman & Co first reported a position in UTMD in Q2 2025 and held it in 4 quarters. The position peaked at $819 in Q3 2025. 114 funds tracked by Wall St. Rank hold UTMD as of Q2 2026.

  • Brown Brothers Harriman & Co reported no remaining Utah Medical Products position as of Q2 2026 after selling out during the quarter.
  • Brown Brothers Harriman & Co sold 13 Utah Medical Products shares in Q2 2026, an estimated $806.
  • Brown Brothers Harriman & Co first reported a position in Utah Medical Products in Q2 2025 and held it in 4 quarters.
  • Brown Brothers Harriman & Co's Utah Medical Products position peaked at $819 in Q3 2025.
  • 114 funds tracked by Wall St. Rank held Utah Medical Products as of Q2 2026.

Based on Brown Brothers Harriman & Co's 13F filing for Q2 2026, filed 12 Aug 2026.